Asia Pacific Biotechnology Markets: A Strategic Analysis of Equity Funding


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

Table of Contents

Asia Pacific Biotechnology Markets, Global ScenarioMarket OverviewIntroductionInvestors—Betting on BiotechBiotech—The Money is in DrugsIn BriefFinancing BiotechnologyPrivate Equity SnapshotCashPublic MarketsVenture InvestmentsMergers & Acquisitions (M&As)Asia Pacific Biotechnology Markets, Asia PacificMarket OverviewIntroductionStatus of BiotechnologyFinancing Biotech in Asia PacificGovernment FundingPublic MarketsVenture CapitalMergers and AcquisitionsAsia Pacific Biotechnology Markets, Strategies for Achieving 'Sustainable Growth'SWOT Analysis of the Asia Pacific Biotech Industry for Equity FundingStrengthsWeaknessOpportunitiesThreatStrategic FinancingFinancing in Strong Equity MarketsFinancing in Weak Equity MarketsVenture FinancingExit StrategiesIntroductionMergers and AcquisitionsIPOsInnovative FundingPartnering for SuccessOther AvenuesAsia Pacific Biotechnology Markets, ConclusionConclusionIn Brief

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.